{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33833368", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "08"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "08"}], "Language": ["eng"], "ELocationID": ["7740", "10.1038/s41598-021-87454-x"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Apr", "Day": "08"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Identification of chlorophyll a-b binding protein AB96 as a novel TGF\u03b21 neutralizing agent.", "Pagination": {"StartPage": "7740", "MedlinePgn": "7740"}, "Abstract": {"AbstractText": ["The discovery of compounds and proteins from plants has greatly contributed to modern medicine. Vernonia amygdalina Del. (Compositae) is used by humans and primates for a variety of conditions including parasitic infection. This paper describes the serendipitous discovery that V. amygdalina extract was able to bind to, and functionally inhibit, active TGF\u03b21. The binding agent was isolated and identified as chlorophyll a-b binding protein AB96. Given that active TGF\u03b21 contributes to the pathology of many infectious diseases, inhibiting these processes may explain some of the benefits associated with the ingestion of this species. This is the first plant-derived cytokine-neutralizing protein to be described and paves the way for further such discoveries."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Excellence for Mass Spectrometry, Denmark Hill, King's College London, London, UK."}], "LastName": "Lynham", "ForeName": "Steven", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Cancer and Pharmaceutical Sciences, King's College London, London, UK."}], "LastName": "Freile", "ForeName": "Fabio Grundland", "Initials": "FG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Cancer and Pharmaceutical Sciences, King's College London, London, UK."}], "LastName": "Puri", "ForeName": "Natasha M", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Peptide Chemistry Science Technology Platform, CRICK, London, UK."}], "LastName": "O'Reilly", "ForeName": "Nicola", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, University of Essex, Colchester, UK."}], "LastName": "Mitchell", "ForeName": "Graham H", "Initials": "GH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicines for Malaria Venture, Geneva, Switzerland."}], "LastName": "Wells", "ForeName": "Timothy N C", "Initials": "TNC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK."}], "LastName": "Willcox", "ForeName": "Merlin", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. richard.1.beatson@kcl.ac.uk."}], "LastName": "Beatson", "ForeName": "Richard", "Initials": "R"}], "GrantList": [{"GrantID": "MR/R000026/1", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Chlorophyll Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amino Acid Sequence"}, {"QualifierName": ["chemistry"], "DescriptorName": "Asteraceae"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Chlorophyll Binding Proteins"}, {"QualifierName": ["chemistry"], "DescriptorName": "Peptides"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Transforming Growth Factor beta1"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ohigashi H, et al. Toward the chemical ecology of medicinal plant use in chimpanzees: The case of Vernonia amygdalina, a plant used by wild chimpanzees possibly for parasite-related diseases. J. Chem. Ecol. 1994;20:541\u2013553. doi: 10.1007/BF02059596.", "ArticleIdList": ["10.1007/BF02059596", "24242110"]}, {"Citation": "Toyang NJ, Verpoorte R. A review of the medicinal potentials of plants of the genus Vernonia (Asteraceae) J. Ethnopharmacol. 2013;146:681\u2013723. doi: 10.1016/j.jep.2013.01.040.", "ArticleIdList": ["10.1016/j.jep.2013.01.040", "23395623"]}, {"Citation": "Wells TN. Natural products as starting points for future anti-malarial therapies: going back to our roots? Malar. J. 2011;10(Suppl 1):S3. doi: 10.1186/1475-2875-10-S1-S3.", "ArticleIdList": ["10.1186/1475-2875-10-S1-S3", "PMC3059461", "21411014"]}, {"Citation": "Abosi AO, Raseroka BH. In vivo antimalarial activity of Vernonia amygdalina. Br. J. Biomed. Sci. 2003;60:89\u201391. doi: 10.1080/09674845.2003.11783680.", "ArticleIdList": ["10.1080/09674845.2003.11783680", "12866916"]}, {"Citation": "Iwalokun BA. Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strains. Afr. Health Sci. 2008;8:25\u201335.", "ArticleIdList": ["PMC2408548", "19357729"]}, {"Citation": "Njan AA, et al. The analgesic and antiplasmodial activities and toxicology of Vernonia amygdalina. J. Med. Food. 2008;11:574\u2013581. doi: 10.1089/jmf.2007.0511.", "ArticleIdList": ["10.1089/jmf.2007.0511", "18800909"]}, {"Citation": "Adedapo AA, Otesile AT, Soetan KO. Assessment of the anthelmintic efficacy of an aqueous crude extract of Vernonia amygdalina. Pharm. Biol. 2008;45:564\u2013568. doi: 10.1080/13880200701498978.", "ArticleIdList": ["10.1080/13880200701498978"]}, {"Citation": "Oyeyemi IT, Akinlabi AA, Adewumi A, Aleshinloye AO, Oyeyemi OT. Vernonia amygdalina: a folkloric herb with anthelminthic properties. Beni-Suef Univ. J. Basic Appl. Sci. 2018;7:43\u201349. doi: 10.1016/j.bjbas.2017.07.007.", "ArticleIdList": ["10.1016/j.bjbas.2017.07.007"]}, {"Citation": "Challand S, Willcox M. A clinical trial of the traditional medicine Vernonia amygdalina in the treatment of uncomplicated malaria. J. Altern. Complement. Med. 2009;15:1231\u20131237. doi: 10.1089/acm.2009.0098.", "ArticleIdList": ["10.1089/acm.2009.0098", "19922255"]}, {"Citation": "Chukwujekwu JC, Lategan CA, Smith PJ, Van Heerden FR, Van Staden J. Antiplasmodial and cytotoxic activity of isolated sesquiterpene lactones from the acetone leaf extract of Vernonia colorata. S. Afr. J. Bot. 2009;75:176\u2013179. doi: 10.1016/j.sajb.2008.10.001.", "ArticleIdList": ["10.1016/j.sajb.2008.10.001"]}, {"Citation": "Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J. Cell. Sci. 2003;116:217\u2013224. doi: 10.1242/jcs.00229.", "ArticleIdList": ["10.1242/jcs.00229", "12482908"]}, {"Citation": "Wahl SM, Wen J, Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol. Rev. 2006;213:213\u2013227. doi: 10.1111/j.1600-065X.2006.00437.x.", "ArticleIdList": ["10.1111/j.1600-065X.2006.00437.x", "16972906"]}, {"Citation": "clinicaltrials.gov."}, {"Citation": "Omer FM, de Souza JB, Corran PH, Sultan AA, Riley EM. Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule. J. Exp. Med. 2003;198:1817\u20131827. doi: 10.1084/jem.20030713.", "ArticleIdList": ["10.1084/jem.20030713", "PMC2194152", "14676296"]}, {"Citation": "Scholzen A, Mittag D, Rogerson SJ, Cooke BM, Plebanski M. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta. PLoS Pathog. 2009;5:e1000543. doi: 10.1371/journal.ppat.1000543.", "ArticleIdList": ["10.1371/journal.ppat.1000543", "PMC2718810", "19680449"]}, {"Citation": "Walther M, et al. Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity. 2005;23:287\u2013296. doi: 10.1016/j.immuni.2005.08.006.", "ArticleIdList": ["10.1016/j.immuni.2005.08.006", "16169501"]}, {"Citation": "Torcia MG, et al. Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA. 2008;105:646\u2013651. doi: 10.1073/pnas.0709969105.", "ArticleIdList": ["10.1073/pnas.0709969105", "PMC2206590", "18174328"]}, {"Citation": "Grainger JR, et al. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J. Exp. Med. 2010;207:2331\u20132341. doi: 10.1084/jem.20101074.", "ArticleIdList": ["10.1084/jem.20101074", "PMC2964568", "20876311"]}, {"Citation": "Li Y, et al. Helminth-induced production of TGF-beta and suppression of graft-versus-host disease is dependent on IL-4 production by host cells. J. Immunol. 2018;201:2910\u20132922. doi: 10.4049/jimmunol.1700638.", "ArticleIdList": ["10.4049/jimmunol.1700638", "PMC6219912", "30291167"]}, {"Citation": "Johnston CJC, et al. A structurally distinct TGF-beta mimic from an intestinal helminth parasite potently induces regulatory T cells. Nat. Commun. 2017;8:1741. doi: 10.1038/s41467-017-01886-6.", "ArticleIdList": ["10.1038/s41467-017-01886-6", "PMC5701006", "29170498"]}, {"Citation": "Loverde PT, Osman A, Hinck A. Schistosoma mansoni: TGF-beta signaling pathways. Exp. Parasitol. 2007;117:304\u2013317. doi: 10.1016/j.exppara.2007.06.002.", "ArticleIdList": ["10.1016/j.exppara.2007.06.002", "PMC2149906", "17643432"]}, {"Citation": "Duru V, Witkowski B, Menard D. Plasmodium falciparum resistance to artemisinin derivatives and piperaquine: a major challenge for malaria elimination in Cambodia. Am. J. Trop. Med. Hyg. 2016;95:1228\u20131238. doi: 10.4269/ajtmh.16-0234.", "ArticleIdList": ["10.4269/ajtmh.16-0234", "PMC5154433", "27928074"]}, {"Citation": "Rider CC, Mulloy B. Heparin, heparan sulphate and the TGF-beta cytokine superfamily. Molecules. 2017 doi: 10.3390/molecules22050713.", "ArticleIdList": ["10.3390/molecules22050713", "PMC6154108", "28468283"]}, {"Citation": "Abe M, et al. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 1994;216:276\u2013284. doi: 10.1006/abio.1994.1042.", "ArticleIdList": ["10.1006/abio.1994.1042", "8179182"]}, {"Citation": "Marshall J, et al. Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry. J. Proteome Res. 2004;3:364\u2013382. doi: 10.1021/pr034039p.", "ArticleIdList": ["10.1021/pr034039p", "15253417"]}, {"Citation": "Salek-Ardakani S, et al. High level expression and purification of the Epstein\u2013Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin. Cytokine. 2002;17:1\u201313. doi: 10.1006/cyto.2001.0990.", "ArticleIdList": ["10.1006/cyto.2001.0990", "11886166"]}, {"Citation": "Beatson R, et al. The breast cancer-associated glycoforms of MUC1, MUC1-Tn and sialyl-Tn, are expressed in COSMC wild-type cells and bind the C-type lectin MGL. PLoS ONE. 2015;10:e0125994. doi: 10.1371/journal.pone.0125994.", "ArticleIdList": ["10.1371/journal.pone.0125994", "PMC4423978", "25951175"]}, {"Citation": "Beatson R, et al. Transforming growth factor-beta1 is constitutively secreted by Chinese hamster ovary cells and is functional in human cells. Biotechnol. Bioeng. 2011;108:2759\u20132764. doi: 10.1002/bit.23217.", "ArticleIdList": ["10.1002/bit.23217", "21618471"]}, {"Citation": "Beatson R, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat. Immunol. 2016;17:1273\u20131281. doi: 10.1038/ni.3552.", "ArticleIdList": ["10.1038/ni.3552", "PMC5257269", "27595232"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "8", "Day": "7"}, {"Year": "2021", "Month": "3", "Day": "15"}, {"Year": "2021", "Month": "4", "Day": "9", "Hour": "6", "Minute": "15"}, {"Year": "2021", "Month": "4", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["33833368", "PMC8032758", "10.1038/s41598-021-87454-x", "10.1038/s41598-021-87454-x"]}}], "PubmedBookArticle": []}